These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27693639)

  • 21. Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.
    Mukudai Y; Kondo S; Fujita A; Yoshihama Y; Shirota T; Shintani S
    Cell Oncol (Dordr); 2013 Jun; 36(3):233-45. PubMed ID: 23529586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines.
    Shin JA; Ryu MH; Kwon KH; Choi B; Cho SD
    J Oral Pathol Med; 2015 Jul; 44(6):420-8. PubMed ID: 25212570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.
    Lin SC; Lin LH; Yu SY; Kao SY; Chang KW; Cheng HW; Liu CJ
    Carcinogenesis; 2018 Dec; 39(11):1320-1330. PubMed ID: 30102337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA hsa_circ_0055538 regulates the malignant biological behavior of oral squamous cell carcinoma through the p53/Bcl-2/caspase signaling pathway.
    Su W; Sun S; Wang F; Shen Y; Yang H
    J Transl Med; 2019 Mar; 17(1):76. PubMed ID: 30857544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of β-catenin.
    Nishikawa Y; Miyazaki T; Nakashiro K; Yamagata H; Isokane M; Goda H; Tanaka H; Oka R; Hamakawa H
    Oncol Rep; 2011 Sep; 26(3):587-92. PubMed ID: 21617878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
    Chuerduangphui J; Ekalaksananan T; Heawchaiyaphum C; Vatanasapt P; Pientong C
    PLoS One; 2020; 15(12):e0242465. PubMed ID: 33332365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
    Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
    BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology.
    Sequeira I; Rashid M; Tomás IM; Williams MJ; Graham TA; Adams DJ; Vigilante A; Watt FM
    Nat Commun; 2020 Nov; 11(1):5671. PubMed ID: 33168804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups.
    India Project Team of the International Cancer Genome Consortium
    Nat Commun; 2013; 4():2873. PubMed ID: 24292195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
    Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
    Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knock-down of ABCE1 gene induces G1/S arrest in human oral cancer cells.
    Wang L; Zhang M; Liu DX
    Int J Clin Exp Pathol; 2014; 7(9):5495-504. PubMed ID: 25337191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effects of BI-D1870 on human oral squamous cell carcinoma.
    Chiu CF; Bai LY; Kapuriya N; Peng SY; Wu CY; Sargeant AM; Chen MY; Weng JR
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):237-47. PubMed ID: 24241211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.
    Velmurugan BK; Lee CH; Chiang SL; Hua CH; Chen MC; Lin SH; Yeh KT; Ko YC
    J Cell Physiol; 2018 Feb; 233(2):1300-1311. PubMed ID: 28516459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.
    Hung CC; Chien CY; Chiang WF; Lin CS; Hour TC; Chen HR; Wang LF; Ko JY; Chang CH; Chen JY
    Oncotarget; 2015 Feb; 6(6):4110-25. PubMed ID: 25686830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
    Yang M; Luo Q; Chen X; Chen F
    J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.